Dr. Beckermann on the Future of Treatment in RCC


In Partnership With:

Kathryn E. Beckermann, MD, PhD, discusses the future of treatment in renal cell carcinoma.

Kathryn E. Beckermann, MD, PhD, assistant professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, discusses the future of treatment in renal cell carcinoma (RCC).

Data reported in RCC over the past year have supported some of the current frontline treatment options in the standard of care, Beckermann says. Since the current frontline treatment landscape has not been challenged by recent data, those in the industry and at institutions need to explore novel ideas to develop improved therapies, Beckermann explains.

These continued efforts across RCC will help define new biomarkers that could lead to more tailored treatments or the ability to monitor response in a noninvasive way, Beckermann concludes.

Related Videos
Kathryn Beckermann, MD, PhD
Eleonora Dondossola, PhD
William B. Pearse, MD
Pasi A. Jänne, MD, PhD, director, Lowe Center for Thoracic Oncology, director, Belfer Center for Applied Cancer Science, director, Chen-Huang Center for EGFR Mutant Lung Cancers, senior physician, David M. Livingston, MD, Chair, Dana-Farber Cancer Institute; professor, medicine, Harvard Medical School
Rachid Baz, MD, section head, Myeloma, Department of Malignant Hematology, Moffitt Cancer Center; co-director, Pentecost Family Myeloma Research Center
Harriet Kluger, MD, Harvey and Kate Cushing Professor of Medicine (Oncology) and of Dermatology; director, Yale SPORE in Skin Cancer; vice chair, Translational Research, Internal Medicine; chief, Division of Skin and Kidney Cancer; associate cancer center director, Education, Training and Faculty Development; deputy section chief, Medical Oncology, Yale Cancer Center
Robert DeBernardo, MD, section head, Obstetrics and Gynecology, Women’s Health Institute, Cleveland Clinic
Jacob Shreve, MD, MS, hematology/oncology fellow, Mayo Clinic
Abhishek Tripathi, MD, genitourinary medical oncologist, City of Hope
Pooja Advani, MBBS, MD, Mayo Clinic